Neutrophil-to-lymphocyte ratio predicts functionally significant coronary artery stenosis in patients with stable

Samet Yılmaz, Uğur Canpolat1, Kazım Başer

  • 1Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey. dru_canpolat@yahoo.com.

Insights

The neutrophil-to-lymphocyte ratio (NLR) is higher in patients with significant coronary artery stenosis. This simple blood test can help predict the severity of blocked arteries in stable coronary artery disease (CAD).

Area of Science:

  • Cardiology
  • Biomarkers
  • Inflammation

Background:

  • Stable coronary artery disease (CAD) affects millions globally.
  • Assessing the functional significance of coronary stenosis is crucial for guiding treatment decisions.
  • Fractional flow reserve (FFR) is a gold standard for evaluating lesion severity, but it is invasive.

Purpose of the Study:

  • To investigate the relationship between the neutrophil-to-lymphocyte ratio (NLR) and the functional severity of coronary stenosis.
  • To determine if NLR can serve as a non-invasive predictor of significant coronary artery stenosis in patients with stable CAD.

Main Methods:

  • Retrospective analysis of clinical and laboratory data from 420 patients with stable angina pectoris.
  • Coronary angiography was performed, and functional severity of intermediate lesions was assessed using FFR.
  • Patients were divided into two groups: non-significant stenosis (FFR >0.80) and significant stenosis (FFR ≤0.80).

Main Results:

  • 137 patients (32.6%) had functionally significant coronary stenosis.
  • Median NLR was significantly higher in patients with significant stenosis compared to those without (3.13 vs 2.22, p<0.001).
  • NLR, along with Gensini score, diabetes, and smoking, independently predicted significant coronary stenosis (OR: 1.62, p<0.001). An NLR cutoff of 2.3 showed 72% sensitivity and 61% specificity.

Conclusions:

  • Pre-angiographic NLR is a simple, non-invasive, and inexpensive biomarker.
  • Elevated NLR is associated with functionally significant coronary stenosis in stable CAD patients.
  • NLR can aid in predicting the hemodynamic severity of intermediate coronary stenosis.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
735
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.6K